Nick Haining

Company: Arsenal Bio

Job title: Co-Founder & Chief Scientific Officer

Seminars:

Developing the Next Generation of CAR-T to Treat Solid Tumours 8:00 am

• Developing autologous T-cells to treat solid tumours using non-viral genome editing • Designing combinatorial synthetic biology to engineer the fate and function of therapeutic T-cells • Creating first-in class autologous T-cell products for solid tumoursRead more

day: Day Two